Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to accelerate the approval of therapies and medicines that were approved by the European Medicines Agency but have not yet been approved for use in the UK by the MHRA.

The Medicines and Healthcare products Regulatory Agency (MHRA) is currently reviewing its licensing procedures, including optimising its processes, the deployment of skills and resource and how applications are differentiated based on risk to prioritise urgent applications. The MHRA is engaging with pharmaceutical companies to ensure early access to innovative medicines in the United Kingdom.